Archives

Why Patient Understanding is the Most Important Metric You Aren’t Tracking

Aayush Sisodia, MSHI, BDS, Business Analytics Advisor, Pharmacy Analytics Health systems are drowning in metrics. We can tell you how many portal messages were answered within 24 hours, how many patients closed a care gap, and how many clinicians are using ambient AI in their notes. But there is one question our dashboards rarely answer: […]

What doctors won’t tell you about Ozempic side-effects

Whether you like them or not, weight-loss drugs have changed the world. Obesity levels in the US, which had been on the rise for years, are falling. National spend on food has shrunk, fashion outlets are selling fewer XXL-sized clothes and, here in the UK, one supermarket has even launched a ‘nutrient dense’ food range, […]

Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide. Epidemiological evidence indicates that MASLD is associated with an increased risk of developing colorectal cancer (CRC). MASLD and CRC share many common risk factors and pathophysiological mechanisms, but an optimal strategy for identifying and managing CRC risk in individuals with […]

Why U.S. airlines love Ozempic

U.S. airlines stand to reap the benefits as more passengers slim down thanks to the popularity of GLP-1 weight-loss drugs. According to a new study by Jefferies equity analyst Sheila Kahyaoglu, airlines could potentially save $580 million annually because lighter passengers mean lighter planes. The same principle applied when airlines slimmed down or removed magazines […]